Dissemin is shutting down on January 1st, 2025

Published in

Scientific Scholar, Indian Journal of Dermatology, Venereology and Leprolog, 4(78), p. 475, 2012

DOI: 10.4103/0378-6323.98079

Links

Tools

Export citation

Search in Google Scholar

Mucous membrane pemphigoid with antibodies against β3 subunit of laminin-332: First report from India

Journal article published in 2012 by Aj Kanwar, Hiroshi Koga, Keshavamurthy Vinay ORCID, Takashi Hashimoto
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Mucous membrane pemphigoid (MMP) is a chronic, recurrent, progressive, subepidermal blistering disorder, mainly affecting the mucous membranes. Anti-laminin 332 MMP is a distinct subset of MMP with antibodies, mainly targeted against α3 or γ2 subunit. Antibodies exclusively against β3 subunit are rarely seen. An internal malignancy is frequently associated with anti-laminin 332 MMP. This disorder usually responds poorly to treatment, requiring multidisciplinary approach. Herein, we describe the first case of anti-laminin-332 MMP from India, which showed antibodies exclusively to β3 subunit.